...
首页> 外文期刊>Inflammation >Asthma and Dehydroepiandrosterone (DHEA): Facts and Hypotheses
【24h】

Asthma and Dehydroepiandrosterone (DHEA): Facts and Hypotheses

机译:哮喘和脱氢表雄酮(DHEA):事实和假设

获取原文
获取原文并翻译 | 示例
           

摘要

Dehydroepiandrosterone (DHEA) is considered as an important immunomodulating and anti-inflammatory hormone. Despite the continuing interest in DHEA replacement therapy, our knowledge of its effects upon asthma is very limited. DHEA is able to reverse cytokine imbalances associated with asthma, may prevent and attenuate allergic inflammation in airways, and does not possess the undesirable side effects of glucocorticoids; therefore, it may be potentially applied in the treatment of asthma. The steroid-sparing effect observed with DHEA clinically could appear especially favorable in asthmatic patients receiving oral treatment and those inhaling high doses of glucocorticoids. In addition, DHEA and its analogs might prove useful in reversing relative glucocorticoids insensitivity in patients with corticosteroid-resistant asthma. In this review we have focused specifically on DHEA’s role in asthma.
机译:脱氢表雄酮(DHEA)被认为是重要的免疫调节和消炎激素。尽管人们一直对DHEA替代疗法产生兴趣,但是我们对它对哮喘的影响的了解非常有限。 DHEA能够逆转与哮喘相关的细胞因子失衡,可以预防和减轻气道过敏性炎症,并且不具有糖皮质激素的不良副作用;因此,它可能潜在地用于哮喘的治疗。在接受口服治疗的哮喘患者和吸入大剂量糖皮质激素的哮喘患者中,用DHEA观察到的在临床上观察到的降低类固醇的效果可能特别有利。此外,DHEA及其类似物可能被证明可用于逆转糖皮质激素抵抗性哮喘患者的相对糖皮质激素敏感性。在这篇评论中,我们特别关注了脱氢表雄酮在哮喘中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号